AngioDynamics Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by AngioDynamics, Inc. on August 5, 2011, reporting events that occurred on August 3, 2011. The filing addresses Item 5.02 regarding the appointment of certain officers and compensatory arrangements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation details.
Material Changes
The Board of Directors approved additional compensation for Scott J. Solano, the Company's Interim CEO, effective August 3, 2011. The compensation package includes:
- A lump sum cash payment of $31,233.
- A grant of 4,617 shares of immediately vested restricted common stock.
- The stock grant was valued at $13.53 per share, based on the NASDAQ Global Market closing price on the grant date.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the specific compensation event reported.
Investor Verification Points
- Verify the total value of the compensation package ($31,233 cash plus stock grant value).
- Confirm the vesting status of the 4,617 restricted stock shares (stated as immediately vested).
- Review the stock price of $13.53 per share against market data for August 3, 2011.
- Check for any subsequent filings regarding the appointment of a permanent CEO.